Enzi Presses FDA on Succession Planning, Leadership Turnover

Drug Industry Daily
A A
Sen. Mike Enzi (R-Wyo.) asked the FDA Monday to clarify an agency report about hiring and retention with more details on succession policies.

To View This Article:

Login

Subscribe To Drug Industry Daily